These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19003944)

  • 1. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
    Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
    Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
    Cebović T; Spasić S; Popović M
    Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
    Stoss M; van Wely M; Musielsky H; Gorter RW
    Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1998 Jun; 3(6):307-14. PubMed ID: 9620894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
    Kirsch A; Hajto T
    J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
    Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
    Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.
    Büssing A; Kochskämper H; Rieger S; Schierholz JM; Schlodder D; Schietzel M
    Anticancer Res; 2007; 27(6B):4195-200. PubMed ID: 18225591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
    von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
    Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
    Gorter RW; van Wely M; Reif M; Stoss M
    Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the effects of aqueous extracts of viscum album (mistletoe) from three host plants on hematological parameters in albino rats.
    Ladokun O; Ojezele M; Arojojoye O
    Afr Health Sci; 2015 Jun; 15(2):606-12. PubMed ID: 26124810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mistletoe, Viscum album coloratum, extract on innate immune response of Nile tilapia (Oreochromis niloticus).
    Park KH; Choi SH
    Fish Shellfish Immunol; 2012 Jun; 32(6):1016-21. PubMed ID: 22554573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
    Büssing A
    Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
    Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
    Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.